Aveanna (AVAH) SVP Stewart sells 29,815 shares to cover equity award taxes

Rhea-AI Filing Summary

Aveanna Healthcare Holdings senior vice president and chief accounting officer Deborah Stewart reported open-market sales of 29,815 shares of common stock over three days. The shares were automatically sold by the company’s stock plan administrator to satisfy her tax obligations on recently vested equity awards, and she continues to hold over 300,000 shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stewart Deborah

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/17/2026		S(1)		7,738	D	$7.6451(2)	323,884	D
Common Stock, par value $0.01 per share	02/18/2026		S(1)		10,896	D	$7.3829(3)	312,988	D
Common Stock, par value $0.01 per share	02/19/2026		S(1)		11,181	D	$7.2082(4)	301,807	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.

2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Aveanna Healthcare (AVAH) executive Deborah Stewart report in this Form 4?

Deborah Stewart reported sales of company common stock totaling 29,815 shares. These transactions occurred over several days and were executed in the open market by the stock plan administrator, according to the filing’s transaction details and accompanying explanatory footnotes.

Why were Deborah Stewart’s Aveanna (AVAH) shares sold in these transactions?

The filing states the shares were automatically sold to satisfy Deborah Stewart’s tax obligations. These obligations arose from shares issued when her equity awards vested, and the stock plan administrator executed the sales on her behalf to cover the related tax liability.

On what dates did Deborah Stewart’s Aveanna (AVAH) stock sales occur?

The reported sales occurred on three dates: February 17, February 18, and February 19, 2026. Each date shows a separate open-market transaction in Aveanna common stock, as detailed in the Form 4 transaction table for non-derivative securities.

How many Aveanna (AVAH) shares did Deborah Stewart sell on each reported date?

She sold 7,738 shares on February 17, 10,896 shares on February 18, and 11,181 shares on February 19, 2026. Together, these Form 4 transactions total 29,815 shares of Aveanna common stock sold to meet tax obligations.

What prices were received in Deborah Stewart’s Aveanna (AVAH) stock sales?

The filing lists weighted average sale prices of $7.6451, $7.3829, and $7.2082 per share for the three transactions. Footnotes explain each is an average across multiple trades within price ranges disclosed for each transaction date.

How many Aveanna (AVAH) shares does Deborah Stewart hold after these transactions?

After the reported sales, Deborah Stewart directly holds over 300,000 Aveanna shares. The Form 4 shows share balances following each transaction, including 301,807 shares remaining after the final open-market sale executed to cover tax obligations.